Accelrys acquisition could stack up to $10 million
Nasdaq-quoted Accelrys, Inc, which has a major presence in Cambridge, has paid around $5 million cash for a long-term Swiss partner. The deal could eventually stack up to $10m based on future performance increments.
Accelrys, which provides scientific innovation lifecycle management software, has bought Vialis AG to solidify its market leadership in the laboratory informatics space. The move also expands the company’s capabilities in the downstream analytical development, quality control, and quality assurance and manufacturing areas.
Vialis is a leading systems integrator based in Liestal and serves the pharmaceutical, biotechnology, chemicals, and agro-science industries. The acquisition includes potential for additional incentive consideration of up to approximately $5 million in cash, contingent upon meeting specified growth objectives over the next three years.
Accelrys President and CEO Max Carnecchia, said: “With demonstrated success in improving laboratory operations by integrating core software systems critical to improving innovation – including electronic laboratory notebooks, laboratory execution systems, and laboratory information management systems – Vialis brings key domain and delivery expertise to Accelrys.
“This acquisition is a natural complement to our two most recent software acquisitions of Velquest and Aegis Corp., furthering our strategy to deliver software solutions that optimise the laboratory-to-commercialisation value chain.”
The entire Vialis team is joining Accelrys, which is headquartered in San Diego and has a Cambridge Science Park hub in Britain. Its solutions are used by more than 1,300 companies in the pharmaceutical, biotechnology, energy, chemicals, aerospace, consumer packaged goods and industrial products industries.
• PHOTOGRAPH SHOWS: Accelrys President and CEO Max Carnecchia. Image courtesy of Accelrys, www.accelrys.com